Combinación de interferones en pacientes con tumores cerebrales de alto grado de malignidad sin opciones terapéuticas.
- Published in:
- Ars Pharmaceutica, 2023, v. 64, n. 4, p. 315, doi. 10.30827/ars.v64i4.27824
- By:
- Publication type:
- Article
Works matching IS 00042927 AND DT 2023 AND VI 64 AND IP 4
Results: 6
1
2
Aquasomal drug delivery system: A special emphasis on the formulation techniques and applications.
- Published in:
- Ars Pharmaceutica, 2023, v. 64, n. 4, p. 359, doi. 10.30827/ars.v64i4.28264
- By:
- Publication type:
- Article
3
Estudio de utilización de nirmatrelvir/ ritonavir en tres centros de atención primaria durante 2022.
- Published in:
- Ars Pharmaceutica, 2023, v. 64, n. 4, p. 342, doi. 10.30827/ars.v64i4.28499
- By:
- Publication type:
- Article
4
Legalización del consumo de cannabis recreativo en adultos y problemas de salud mentales.
- Published in:
- Ars Pharmaceutica, 2023, v. 64, n. 4, p. 348, doi. 10.30827/ars.v64i4.28681
- By:
- Publication type:
- Article
5
Solubility data and solubility parameters of barnidipine in different pure solvents.
- Published in:
- Ars Pharmaceutica, 2023, v. 64, n. 4, p. 329, doi. 10.30827/ars.v64i4.27728
- By:
- Publication type:
- Article
6
Ecdiesteroides y su actividad farmacológica sobre el músculo esquelético.
- Published in:
- Ars Pharmaceutica, 2023, v. 64, n. 4, p. 376, doi. 10.30827/ars.v64i4.28863
- By:
- Publication type:
- Article